Mettler-Toledo (MTO) Stock Forecast & Price Target

3 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MTO Analyst Ratings

Moderate Buy

6 Buy

6 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Mettler-Toledo

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MTO Stock 12 Month Forecast

Average Price Target

€1,235.49

▲(5.96% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Mettler-Toledo in the last 3 months. The average price target is €1,235.49 with a high forecast of €1,387.74 and a low forecast of €1,023.46. The average price target represents a 5.96% change from the last price of €1,166.00.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1021":"€1,021","1388":"€1,388","1112.75":"€1,112.8","1204.5":"€1,204.5","1296.25":"€1,296.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1387.74328,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€1.39K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1235.4857644499998,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€1.24K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1023.460669,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€1.02K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1021,1112.75,1204.5,1296.25,1388],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1200,1214.4417907692307,1228.8835815384616,1243.3253723076923,1257.767163076923,1272.2089538461537,1286.6507446153846,1301.0925353846153,1315.534326153846,1329.976116923077,1344.4179076923076,1358.8596984615383,1373.3014892307692,{"y":1387.74328,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1200,1202.7296741884616,1205.4593483769231,1208.1890225653847,1210.918696753846,1213.6483709423076,1216.3780451307691,1219.1077193192307,1221.8373935076922,1224.5670676961538,1227.2967418846151,1230.0264160730767,1232.7560902615382,{"y":1235.4857644499998,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1200,1186.4200514615384,1172.840102923077,1159.2601543846154,1145.680205846154,1132.1002573076923,1118.5203087692307,1104.9403602307693,1091.3604116923077,1077.780463153846,1064.2005146153847,1050.620566076923,1037.0406175384617,{"y":1023.460669,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1073,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1101.5,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1087.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1228,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1270,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1157,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1159.5,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1135,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1103.5,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1058,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1022,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1116,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1200,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€1,388

Average Price Target€1,235

Lowest Price Target€1,023

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Casey Woodring

J.P. Morgan

€1,040.81→€1,214.28

Hold

4.14%

Upside

Reiterated

08/04/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Neuren Pharmaceuticals Limited (Other OTC: NURPF), Mettler-Toledo (NYSE: MTD) and Dexcom (NASDAQ: DXCM)

Kallum Titchmarsh

Morgan Stanley

€1,105.86→€1,257.64

Hold

7.86%

Upside

Assigned

08/04/26

Mettler-Toledo: Robust Q2 and Raised Guidance Drive Price Target Increase to $1,450, But Valuation Keeps Rating at Hold

Unknown Analyst

Wells Fargo

Not Ranked

Wells Fargo

€1,062.49→€1,257.64

Hold

7.86%

Upside

Assigned

08/03/26

Wells Fargo Sticks to Their Hold Rating for Mettler-Toledo (MTD)

Daniel Arias

Stifel Nicolaus

€1,214.28→€1,387.74

Buy

19.02%

Upside

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Disc Medicine (NASDAQ: IRON), Mettler-Toledo (NYSE: MTD) and Moderna (NASDAQ: MRNA)

Luke Sergott

Barclays

€1,127.54→€1,366.06

Buy

17.16%

Upside

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Mettler-Toledo (NYSE: MTD), AnaptysBio (NASDAQ: ANAB) and Alnylam Pharma (NASDAQ: ALNY)

Tycho Peterson

Jefferies

€1,214.28→€1,370.4

Buy

17.53%

Upside

Reiterated

07/31/26

Mettler-Toledo price target raised to $1,580 from $1,400 at JefferiesMettler-Toledo price target raised to $1,580 from $1,400 at Jefferies

Michael Ryskin

Bank of America Securities

―

Buy

―

Reiterated

07/31/26

Analysts Offer Insights on Healthcare Companies: AptarGroup (NYSE: ATR), Mettler-Toledo (NYSE: MTD) and Dexcom (NASDAQ: DXCM)

Evie Koslosky

Goldman Sachs

€1,214.28→€1,162.23

Hold

-0.32%

Downside

Reiterated

07/31/26

Hold Rating Maintained on Mettler-Toledo as Solid Q2 Results Lead to Higher Guidance but Price Target Trimmed from $1400 to $1340

Patrick B Donnelly

Citi

€1,344.38

Buy

15.30%

Upside

Reiterated

07/08/26

Analysts Offer Insights on Healthcare Companies: Helus Pharma (NASDAQ: HELP) and Mettler-Toledo (NYSE: MTD)

Vijay Kumar

Evercore ISI

€1,127.54→€1,170.91

Buy

0.42%

Upside

Reiterated

07/06/26

Mettler-Toledo price target raised to $1,350 from $1,300 at Evercore ISIMettler-Toledo price target raised to $1,350 from $1,300 at Evercore ISI

Michael Polark

Wolfe Research

€1,023.46

Hold

-12.22%

Downside

Initiated

06/01/26

Mettler-Toledo initiated with a Peer Perform at Wolfe ResearchMettler-Toledo initiated with a Peer Perform at Wolfe Research

Catherine Ramsey Schulte

Robert W. Baird

€1,253.31→€1,035.6

Hold

-11.18%

Downside

Reiterated

05/11/26

Mettler-Toledo price target lowered to $1,194 from $1,445 at BairdMettler-Toledo price target lowered to $1,194 from $1,445 at Baird

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Casey Woodring

J.P. Morgan

€1,040.81→€1,214.28

Hold

4.14%

Upside

Reiterated

08/04/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Neuren Pharmaceuticals Limited (Other OTC: NURPF), Mettler-Toledo (NYSE: MTD) and Dexcom (NASDAQ: DXCM)

Kallum Titchmarsh

Morgan Stanley

€1,105.86→€1,257.64

Hold

7.86%

Upside

Assigned

08/04/26

Mettler-Toledo: Robust Q2 and Raised Guidance Drive Price Target Increase to $1,450, But Valuation Keeps Rating at Hold

Unknown Analyst

Wells Fargo

Not Ranked

Wells Fargo

€1,062.49→€1,257.64

Hold

7.86%

Upside

Assigned

08/03/26

Wells Fargo Sticks to Their Hold Rating for Mettler-Toledo (MTD)

Daniel Arias

Stifel Nicolaus

€1,214.28→€1,387.74

Buy

19.02%

Upside

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Disc Medicine (NASDAQ: IRON), Mettler-Toledo (NYSE: MTD) and Moderna (NASDAQ: MRNA)

Luke Sergott

Barclays

€1,127.54→€1,366.06

Buy

17.16%

Upside

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Mettler-Toledo (NYSE: MTD), AnaptysBio (NASDAQ: ANAB) and Alnylam Pharma (NASDAQ: ALNY)

Tycho Peterson

Jefferies

€1,214.28→€1,370.4

Buy

17.53%

Upside

Reiterated

07/31/26

Mettler-Toledo price target raised to $1,580 from $1,400 at JefferiesMettler-Toledo price target raised to $1,580 from $1,400 at Jefferies

Michael Ryskin

Bank of America Securities

―

Buy

―

Reiterated

07/31/26

Analysts Offer Insights on Healthcare Companies: AptarGroup (NYSE: ATR), Mettler-Toledo (NYSE: MTD) and Dexcom (NASDAQ: DXCM)

Evie Koslosky

Goldman Sachs

€1,214.28→€1,162.23

Hold

-0.32%

Downside

Reiterated

07/31/26

Hold Rating Maintained on Mettler-Toledo as Solid Q2 Results Lead to Higher Guidance but Price Target Trimmed from $1400 to $1340

Patrick B Donnelly

Citi

€1,344.38

Buy

15.30%

Upside

Reiterated

07/08/26

Analysts Offer Insights on Healthcare Companies: Helus Pharma (NASDAQ: HELP) and Mettler-Toledo (NYSE: MTD)

Vijay Kumar

Evercore ISI

€1,127.54→€1,170.91

Buy

0.42%

Upside

Reiterated

07/06/26

Mettler-Toledo price target raised to $1,350 from $1,300 at Evercore ISIMettler-Toledo price target raised to $1,350 from $1,300 at Evercore ISI

Michael Polark

Wolfe Research

€1,023.46

Hold

-12.22%

Downside

Initiated

06/01/26

Mettler-Toledo initiated with a Peer Perform at Wolfe ResearchMettler-Toledo initiated with a Peer Perform at Wolfe Research

Catherine Ramsey Schulte

Robert W. Baird

€1,253.31→€1,035.6

Hold

-11.18%

Downside

Reiterated

05/11/26

Mettler-Toledo price target lowered to $1,194 from $1,445 at BairdMettler-Toledo price target lowered to $1,194 from $1,445 at Baird

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

AMLXAmylyx Pharmaceuticals Inc

TNYATenaya Therapeutics

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Mettler-Toledo

3 Months

Vijay KumarEvercore ISI

Success Rate

6/9 ratings generated profit

Average Return

+2.47%

Copying Vijay Kumar's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +2.47% per trade.

1 Year

Vijay KumarEvercore ISI

Success Rate

8/9 ratings generated profit

Average Return

+3.30%

Copying Vijay Kumar's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +3.30% per trade.

2 Years

Patrick B DonnellyCiti

Success Rate

9/10 ratings generated profit

Average Return

+14.18%

Copying Patrick B Donnelly's trades and holding each position for 2 Years would result in 90.00% of your transactions generating a profit, with an average return of +14.18% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MTO Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MTO has received 6 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. MTO average Analyst price target in the past 3 months is 1,235.49.

Each month's total comprises the sum of three months' worth of ratings.

MTO Financial Forecast

MTO Earnings Forecast

Next quarter’s earnings estimate for MTO is €10.47 with a range of €10.44 to €10.60. The previous quarter’s EPS was €9.91. MTO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 37.50% of the time in the same period. In the last calendar year MTO has Performed in-line its overall industry.

MTO Sales Forecast

Next quarter’s sales forecast for MTO is €926.17M with a range of €923.54M to €929.82M. The previous quarter’s sales results were €888.58M. MTO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.91% of the time in the same period. In the last calendar year MTO has Performed in-line its overall industry.

MTO Stock Forecast FAQ

What is DE:MTO’s average 12-month price target, according to analysts?

Based on analyst ratings, Mettler-Toledo International’s 12-month average price target is 1,235.49.

What is DE:MTO’s upside potential, based on the analysts’ average price target?

Mettler-Toledo International has 5.96% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Mettler-Toledo International a Buy, Sell or Hold?

Mettler-Toledo International has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 6 hold ratings and 0 sell ratings.

What is Mettler-Toledo International’s share price target?

The average share price target for Mettler-Toledo International is 1,235.49. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €1,387.74 ,and the lowest forecast is €1,023.46. The average share price target represents 5.96% Increase from the current price of €1,166.

What do analysts say about Mettler-Toledo International?

Mettler-Toledo International’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of Mettler-Toledo International?

To buy shares of DE:MTO, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Mettler-Toledo (MTO) Stock Forecast & Price Target

MTO Analyst Ratings

MTO Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Mettler-Toledo

MTO Analyst Recommendation Trends

MTO Financial Forecast

MTO Earnings Forecast

MTO Sales Forecast

MTO Stock Forecast FAQ

Detailed List of Analyst Forecasts